Department of Medicine
About UsDedicated to the future of care
The Department of Medicine provides residents with a thorough, broad-based education while giving patients individualized care through Feinberg-affiliated hospitals and care sites and conducting high-level basic and clinical research through our 12 specialized internal medicine divisions.
The unique culture at the Department of Medicine is built on its rich history of research and clinical innovation embedded in an exceptional clinical environment, driven by faculty and staff whose commitment and talent create patient care improvements through scientific advance.
These extraordinary strengths allow the Department to adapt to tremendous challenges and opportunities that are arising in healthcare. We have seen more change over recent years than in many preceding decades. As each of us contributes to expanding what we can achieve, we are driven by the same core mission: Patients First.”
What We Do
Faculty Spotlight
Associate Professor of Medicine (Endocrinology) and Preventive Medicine (Epidemiology)
My clinical research is focused on the disease state of diabetes mellitus, with application to high risk populations such as solid organ transplant patients. My research portfolio includes retrospective cohort studies, small and large clinical trials and intervention studies, and quantitative research methods examining patient safety and quality improvement.
Associate Professor of Medicine (Cardiology) and Pediatrics
Adult Congenital Heart disease Heart disease and Pregnancy with ongoing research in Preconception evaluation Women's cardiovascular health during her lifetime
Professor of Medicine (Pulmonary and Critical Care)
Dr. Robert Cohen is Professor of Medicine and Director of Occupational Lung Disease.Dr. Cohen has practiced clinical pulmonary medicine for more than 30 years and is board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and has been a Certified NIOSH B-Reader since 1998. Dr. Cohen has a broad background in public health, occupational lung disease and has been an investigator in the area of respiratory disease in populations of occupationally exposed workers.
Clinical Associate Professor of Medicine (Endocrinology)
Concierge medicine practice doing primary care and diabetes for a smaller number of patients.
Associate Professor of Medicine (Pulmonary and Critical Care) and Cell and Developmental Biology
Cell-cell adhesion in health and disease
Assistant Professor of Medicine (Gastroenterology and Hepatology)
I perform primary and secondary endoscopic (non-surgical) therapies for obesity, including placement of the Orbera gastric balloon, the Aspire Assist device and endoscopic sleeve gastroplasty. I also perform gastro-jejunal outlet reduction for weight regain after bariatric surgery. I have also been trained to use the EsophyX device (TIF procedure) as a minimally invasive (non-surgical) treatment for GERD. I am also interested in endoscopic treatment of post-surgical complications and endoscopic suturing.
Associate Professor of Medicine (Cardiology)
As the Director of Cardiac Electrophysiology Laboratory at Northwestern Memorial Hospital, Dr. Chicos has a busy clinical practice with a broad range of clinical and research interests in the field of Heart Rhythm Disorders. His interests include prevention of sudden death; cardiac resynchronization; catheter ablation for complex arrhythmias, including ventricular tachycardia, post-maze atrial flutter and atrial fibrillation; cryoballoon ablation for atrial fibrillation; epicardial ablation of ventricular tachycardia; and screening, diagnosis and prevention of sudden death in patients with car...
Professor of Medicine (Hematology and Oncology)
My clinical domain is breast cancer management. My clinical research interest focuses on the development of novel therapies for the treatment of breast cancer. Clinical trials focusing on precision medicine for defining the right therapy, for the right patient at the right time is our goal. To that end, molecular interogation of breast tumors are leading to novel trial design that will hopefully translate into better outcomes for our patients. In conjuction with the developmental therapeutics program, novel agents are being incorporated into clinical trials for patients with both early and lat...
